Article
Gain of function of p53 cancer mutants in disrupting critical DNA damage response pathways.
Cell cycle (Georgetown, Tex.) - 1 Jul 2007
Song Hoseok, Xu Yang
Abstract excerpt
Loss of the tumor suppression activity of p53 is required for the progression of most human cancers. In this context, p53 gene is somatically mutated in about half of all human cancers; in the rest human cancers, p53 is mostly inactivated due to the disruption of pathways important for its activation. Most p53 cancer mutations are missense mutations within the core domain, leading to the expression of full-length...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
